Is xgeva given as an iv or a subcutaneous shot?

IV vs Subcutaneous Injection: Understanding Xgeva Administration

Xgeva (denosumab) is a medication used to prevent bone damage, fractures, and other skeletal events in patients with certain types of cancer, such as breast cancer, prostate cancer, and multiple myeloma [1].

What type of administration is Xgeva given?

Xgeva is primarily administered via subcutaneous injection, given every 4 weeks. However, according to the prescribing information, a loading dose of 120 mg is administered via intravenous (IV) injection, and then a 120 mg dose is administered subcutaneously one week later, and a 120 mg dose administered subcutaneously every 4 weeks thereafter [2].

Why is Xgeva typically given subcutaneously?

Subcutaneous injection is often preferred over IV injection due to its convenience and ease of administration. Subcutaneous injections can be given at home or in a clinic, and they typically cause less discomfort and pain compared to IV injections [3].

Can Xgeva be administered through IV if subcutaneous is not possible?

In some cases, patients may not be able to receive subcutaneous injections due to certain medical conditions or physical limitations. In these cases, Xgeva can be administered intravenously, although IV administration should only be performed in a healthcare setting by a trained healthcare professional [2].

Patient concerns and questions

Some patients may wonder how they can ensure they receive their Xgeva injections on schedule. According to the manufacturer, patients should work closely with their healthcare provider to schedule their injections and to address any concerns or questions they may have [1].

References

[1] Amgen. (2023). XGEVA (denosumab) Prescribing Information. Retrieved from https://www.xgeva.com/prescribing-information.pdf

[2] US Food and Drug Administration. (2023). Xgeva (denosumab) Injection. Retrieved from https://www.fda.gov/drugs/atf-audiences/pharmaceutical-companies/xgeva-denosumab-injection

[3] Hospira. (2019). Subcutaneous Injection Administration. Retrieved from https://www.hospira.com/en/injectionadministration/subcutaneo us_injectionadministration.html